Search Results

You searched for : Nivolumab  

	How the Immune System is Transforming Cancer Treatment Immunotherapy is a drug used in the treatment of cancer. It is a new modality of treatment. immunotherapy is given intravenously (injection) usually at 2 ... Jun 30
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
	Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
	Bristol Myers Squibb Announces RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo The antibody is indicated for patients with previously untreated Metastatic or unresectable melanoma... Mar 27
	Compugen expands clinical collaboration agreement with Bristol Myers Squibb Compugen Ltd expands collaboration agreement with Bristol Myers Squibb with phase 1b combination study of COM701 with opdivo C... Feb 22
	European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo ... Jan 05
	Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme ... Dec 23
	Bristol Myers Squibb Receives European Commission Approval for Opdivo Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ... Nov 25
	Bristol Myers Squibb Receives European Commission approval for Opdivo plus Yervoy for treatment of Lung Cancer European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is approved for patients with non-small cell lung cancer in the ... Nov 09
	USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma Results from CheckMate -9ER recently presented during a Presidential Symposium at the European Society for Medical Oncology Virtual Congress... Oct 19
	Sumitomo announces first patient dosed with TP-1454 : result awaited Sumitomo Dainippon Pharma Oncology announces first patient dosed with TP-1454 in patients with advanced solid tumours ... Oct 10
	US FDA approves drug combination for treating mesothelioma US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
	Bristol Myers Squibbs get FDA approval for Opdivo and Yervoy : Malignant Pleural Mesothelioma Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ... Oct 03
	City of Hope collaborates with Chimeric to develop cell therapy City of Hope enters licensing agreement with Chimeric Therapeutics Limited to develop its pioneering chlorotoxin CAR T Cell therapy ... Sep 22
	Compugen Reports 4th Quarter and Full Year 2019 Result Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today declared their 4th and full year report.... Feb 21
	IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th ... Sep 13
	Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
18 Matching result(s) found!

Trending Now
	Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
	Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026
	Prostate Health Awareness: What Every Indian Man Needs to KnowAugust 07, 2026
	Testosterone Levels Explained: Normal Ranges by Age, Causes of Imbalance, and What to DoAugust 07, 2026
	“AI can read a chest X-ray in 1.3 seconds” says Dr. Marios Loukas, President and Dean of the School of Medicine, St. George’s UniversityAugust 06, 2026
	UK Mental Healthcare Leader Care ADHD To Open Its First Clinic in Bengaluru This October, Bringing NHS-Backed ADHD Care Model to IndiaAugust 06, 2026
	Aster DM Quality Care Reports Strong Q1 FY27: Revenue Up 20 Per Cent to Rs 2,597 Cr, Operating EBITDA Up 30 Per CentAugust 06, 2026
	What Happens to Your Body During an All-Nighter?August 06, 2026
	Childhood Obesity in India: A Growing Public Health Crisis That Demands Urgent AttentionAugust 06, 2026
	Screen Time Effects on Children: What Every Indian Parent and Paediatrician Needs to KnowAugust 06, 2026
	Kidney Transplant Recipient Defeats CancerAugust 05, 2026
	Fermenta Biotech Lists on India’s National Stock ExchangeAugust 05, 2026
	Asia Pacific leaders warn attacks against health and gender are undoing decades of progressAugust 05, 2026
	Understanding Long-Term Impacts of Air Purification on ImmunityAugust 05, 2026
	Understanding Epigenetics: How Lifestyle Changes Your DNAAugust 05, 2026
	CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
	Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
	Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
	Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
	A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026